País: Unión Europea
Idioma: español
Fuente: EMA (European Medicines Agency)
Istradefylline
Kyowa Kirin Holdings B.V.
N04
istradefylline
Medicamentos contra el Parkinson
Mal de Parkinson
Istradefylline is indicated in adults as an adjunctive treatment to levodopa based regimens in patients with Parkinson’s disease (PD) experiencing “OFF” time.
Rehusó